2 citations
,
November 2014 in “Pharmaceutical Patent Analyst” This article provides an update on several international patent cases, including a decision that could change Japan's patent term extension practice, but it reports no new research results.
7 citations
,
April 2017 in “Health Economics, Policy and Law” This review analyzes current patent trends in personalized medicine, suggesting they often privilege the pharmaceutical industry without adequately demonstrating overall public benefit.
30 citations
,
June 2008 in “Dermatologic Surgery” In this study, the SAFE System for follicular unit extraction demonstrated a favorable average follicle transection rate of 6.14% and is accessible for physicians with basic technical skills, showing promise for wider adoption.
3 citations
,
October 2002 in “Journal of The American Academy of Dermatology” This commentary disputes Beckett et al.'s conclusion that boron exposure causes reversible alopecia, suggesting instead that alopecia areata is a more plausible cause based on patient histories and typical clinical features.
This letter humorously reflects on aging and disputes the notion of "Geezer syndrome" linked to the Great Depression, emphasizing resilience and growth in knowledge over time.